The European Medicines Agency is set to decide this week whether to recommend pan-EU marketing authorization for Estelle (estetrol/drospirenone), the potential blockbuster oral contraceptive from Mithra.
Estelle, which was approved for the first time worldwide this month when Canada gave it the thumbs up, marks a...